2-(1-(1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)-4-sulfanyl-3-piperidinylidene) acetic acid

DB19221InvestigationalSmall molecule

2-(1-(1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)-4-sulfanyl-3-piperidinylidene) acetic acid is under investigation in clinical trial NCT03774394 (Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus).

Chemical structure of 2-(1-(1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)-4-sulfanyl-3-piperidinylidene) acetic acid
Formula / weight
C16H18ClNO4S · 355.83 g/mol (avg)
Also known as
1-piperidineacetic acid, 3-(carboxymethylene)-.alpha.-(2-chlorophenyl)-4-mercapto-, 1-methyl ester, (.alpha.s,3z)- · 3-(carboxymethylene)-.alpha.-(2-chlorophenyl)-4-mercapto-1-piperidineacetic acid 1-methyl ester, (.alpha.s,3z)- · Clopidogrel active metabolite

Resolves to

Structure
InChIKeyCWUDNVCEAAXNQA-AWGNNQSZSA-NSMILESCOC(=O)[C@@H](N1CCC(S)\C(C1)=C/C(O)=O)C1=CC=CC=C1Cl

What you can answer from here — as of April 02, 2025

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of 2-(1-(1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)-4-sulfanyl-3-piperidinylidene) acetic acid, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.

Create Account